Bipolar Archael Glycolipid Analogues
A R T I C L E S
tion of triflate (691 mg, 1.52 mmol, 1.6 equiv) in dry tetrahydrofuran
(2 mL), a suspension of alcohol 22 (500 mg, 0.96 mmol, 1 equiv) and
potassium hydride (35% in oil) (150 mg, 1.15 mmol, 1.2 equiv) in 6
mL of dry THF was added at 0 °C. The suspension was stirred for a
few minutes at room temperature before water was added, and the
resulting mixture was extracted with ether. The combined extracts were
dried over MgSO4, and the solvent was removed under reduced pressure.
The crude product was purified by column chromatography on silica
gel with a mixture of petroleum ether and ethyl acetate (95/5) to yield
68.7, 69.0, 69.1, 70.2, 70.3, 70.5, 70.7, 71.0, 71.6, 71.7, 71.8, 72.5,
72.9, 76.2, 77.7, 78.3, 100.7, 101.0, 169.3, 169.7, 170.0, 170.3, 170.4,
170.6, 170.7; elemental analysis calcd (%) for C71H124O23: C, 63.37;
H, 9.29. Found: C, 63.09; H, 9.21.
3,3′-O-[1,18-Octadecan-(cis-8,11-methylidene)-methylene]-2,2′-di-
O-[3-(R)-7-dimethyloctyl]-1-O-[4-O-(â-D-galactopyranosyl)-â-D-glu-
copyranosyl]-1′-O-(â-D-galactofuranosyl)-sn-diglycerol (1). Com-
pound 27 (51 mg, 0.04 mmol, 1 equiv) and pent-4-enyl 2,3,5,6-tetra-
O-acetyl-R,â-D-galactofuranoside 26 (24 mg, 0.06 mmol, 1.5 equiv)
were combined, rotoevaporated twice with toluene, and then dried for
2 h under vacuum. A solution of this mixture in dry CH2Cl2 (2 mL)
was added to 4 Å molecular sieves. The mixture was treated at 0 °C
under N2 and in the dark with N-iodosuccinimide (34 mg, 0.16 mmol,
4 equiv) followed by dropwise addition of triethylsilyl trifluo-
romethanesulfonate (6.8 µL, 0.03 mmol, 0.8 equiv). The reaction was
quenched with a few drops of triethylamine after 10 min at room
temperature. The resulting solution was diluted with CH2Cl2, washed
successively with 10% aqueous sodium thiosulfate, water, and brine,
dried over MgSO4, and rotoevaporated. The crude product was purified
with silica gel column chromatography with petroleum ether/EtOAc
(7:3) to give the acetylated bisglycosylated lipid as a colorless oil (22
mg, 35%); Rf ) 0.3 (EP/EtOAc 6:4 v/v); [R]20D -11.5° (c 1, CHCl3);
1H NMR (400 MHz, CDCl3) δ 0.57 (m, 1H, J ) 10.2 Hz), 0.78-0.80
(m, 18H), 0.97-1.73 (m, 50H), 1.78-1.85 (m, 1H), 1.90-2.09 (m,
33H), 3.31-3.55 (m, 17H), 3.69 (q, 1H, J ) 4.0 Hz), 3.72 (t, 1H, J )
9.6 Hz), 3.79-3.84 (m, 2H), 3.99-4.09 (m, 3H), 4.15 (m, 1H), 4.18
(m, 1H), 4.26 (dd, 1H, J ) 4.3, 11.9 Hz), 4.40 (m, 2H), 4.48 (d, 1H,
J ) 7.9 Hz), 4.82-4.93 (m, 3H), 5.00 (m, 2H), 5.05 (m, 1H), 5.12 (t,
1H, J ) 9.2 Hz), 5.27 (d, 1H, J ) 3.1 Hz), 5.32 (m, 1H); 13C NMR
(400 MHz, CDCl3) δ 19.7, 19.8, 20.6, 20.9, 22.7, 22.8, 24.7-39.3,
40.2, 40.8, 60.8, 62.1, 62.8, 66.6, 67.5, 69.0, 69.2, 69.1, 69.3, 70.5,
70.7, 71.0, 71.7, 71.8, 72.6, 72.9, 76.4, 76.6, 77.7, 77.9, 79.9, 81.3,
100.9, 101.2, 105.8, 169.2, 170.6; elemental analysis calcd (%) for
C85H142O32: C, 60.91; H, 8.54. Found: C, 61.24; H, 8.72. A solution
of sodium methoxide in CH3OH (0.1 M, 131 µL) was added to a
solution of the acetylated bisglycosylated lipid (22 mg, 0.013 mmol)
in 2 mL of CH3OH. The mixture was stirred for 2 h at room
temperature, neutralized with a solution of acetic acid in methanol and
concentrated under vacuum. The crude product was purified by silica
gel column chromatography (CHCl3/MeOH/H2O 7:3:0.5) to yield 1 as
a pasty solid (16 mg, >95%); Rf ) 0.7 (CHCl3/MeOH/H2O 7:3:0.5
the corresponding acyclic compound (411.5 mg, 50%) as a colorless
1
oil; Rf ) 0.6 (EP/EtOAc 8:2 v/v); [R]20 -4.0° (c 0.8. CHCl3); H
D
NMR (400 MHz, CDCl3) δ 0.64 (m, 1H, J ) 10.7 Hz), 0.85 (m, 18H),
1.10-1.73 (m, 50H), 1.91 (m, 1H), 3.41-3.64 (m, 18H), 4.01 (d, 2H,
J ) 5.6 Hz), 4.55 (s, 2H), 5.17 (d, 1H, J ) 10.4 Hz), 5.27 (d, 1H, J )
17.0 Hz), 5.90 (m, 1H, J ) 5.6 Hz), 7.26-7.34 (m, 5H); 13C NMR
(400 MHz, CDCl3) δ 19.7, 22.7, 22.8, 24.7-40.2, 68.9, 69.0, 70.3,
70.8, 71.7, 71.9, 72.4, 73.4, 78.0, 116.9, 127.6, 127.7, 128.4, 138.5,
134.9. To a solution of this compound (50 mg, 0.077 mmol) in a mixture
of toluene/EtOH/H2O (1.25 mL:2.65 mL:400 µL), Wilkinson catalyst
(Ph3P)3RhCl (15 mg, 0.016 mmol, 0.2 equiv) was added. The reaction
mixture was heated at 100 °C for 24 h and stirred 12 h at room
temperature. After removal of solvent, the residue was dissolved in
diethyl ether. The organic layer was washed with water and brine, dried
(MgSO4), filtered, and concentrated under vacuum. The residue was
purified by silica gel column chromatography eluting with a mixture
of petroleum ether/EtOAc (95:5 v/v) to yield compound 24 (47 mg,
78%) as a colorless oil; Rf ) 0.3 (EP/EtOAc 8/2 v/v); [R]20D +12.2° (c
1
1.07, CHCl3); H NMR (400 MHz, CDCl3) δ 0.65 (m, 1H, J ) 10.9
Hz), 0.87 (m, 18H), 1.00-1.73 (m, 50H), 1.90 (m, 1H), 2.22 (s, 1H),
3.41-3.71 (m, 18H), 4.56 (s, 2H), 7.26-7.34 (m, 5H);13C NMR (400
MHz, CDCl3) δ 19.7, 22.7, 22.8, 24.7-40.7, 63.2, 68.7, 68.9, 70.3,
70.8, 71.0, 71.7, 72.2, 73.4, 78.0, 78.3, 127.6, 127.7, 128.4, 138.4;
elemental analysis calcd (%) for C52H96O6: C, 76.42; H, 11.84.
Found: C, 76.95; H, 11.98.
3,3′-O-[1,18-Octadecan-(cis-8,11-methylidene)-methylene]-2,2′-di-
O-[3-(R)-7-dimethyloctyl]-1-O-[2,3,6-tri-O-acetyl-4-O-(2,3,4,6-tetra-
O-acetyl-â-D-galactopyranosyl)-â-D-glucopyranosyl]-sn-diglycerol (27).
Compound 17 (109 mg, 0.13 mmol) and lactosyl thioglycoside 25 (136
mg, 0.2 mmol, 1.5 equiv) were combined, rotoevaporated twice with
toluene, and then dried for 2 h under vacuum. A solution of this mixture
in dry CH2Cl2 (4.5 mL) was added to 4 Å molecular sieves. The mixture
was treated at 0 °C under N2 and in the dark with N-iodosuccinimide
(60 mg, 0.27 mmol, 2 equiv) followed by dropwise addition of
triethylsilyl trifluoromethanesulfonate (12 µL, 0.05 mmol, 0.4 equiv).
The reaction was quenched with a few drops of triethylamine after 5
min at room temperature. The resulting solution was diluted with CH2-
Cl2, washed successively with 10% aqueous sodium thiosulfate, water,
and brine, dried over MgSO4, and rotoevaporated. The crude product
was purified with silica gel column chromatography with petroleum
ether/EtOAc 7:3 to give the acetylated lactosylated lipid (89 mg, 48%);
Rf ) 0.5 (EP/EtOAc 6:4 v/v); [R]20D -5.2° (c 1, CHCl3) as a colorless
oil. To a solution of this product (55 mg, 0.04 mmol) in ethanol (2
mL), 10% palladium on activated charcoal (10 mg) was added. The
solution was stirred under H2 atmosphere overnight. The catalyst was
removed by filtration, and the filtrate was concentrated to dryness. A
purification by column chromatography on silica gel (petroleum ether/
EtOAc 7:3)) gave the deprotected monoglycosylated lipid 27 (51 mg,
v/v); mp ) 125-130 °C; [R]20 -16.4° (c 1, MeOH/CHCl3 1:1 v/v);
D
1H NMR (400 MHz, CDCl3) δ 0.59 (m, 1H), 0.80 (m, 18H), 0.95-
1.68 (m, 51H), 3.14-3.91 (m, 36H), 4.24 (2d, 2H, J ) 7.4 Hz), 4.80
(m, 1H); 13C NMR (400 MHz, CDCl3) δ 20.19, 20.23, 23.1, 23.2, 25.9-
40.5, 41.2, 41.4, 41.9, 61.9, 62.4, 64.5, 68.4, 69.6, 69.7, 70.2, 70.3,
70.0, 71.8, 72.4, 72.5, 72.6, 72.8, 74.7, 74.8, 76.3, 76.5, 77.1, 78.9,
79.2, 79.3, 80.5, 83.2, 84.6, 104.6, 105.1, 109.7; FABMS (m-nitrobenzyl
alcohol matrix) calcd for [M + Na]+, 1235.8220; found, 1235.8217.
3,3′-O-[1,18-Octadecan-(cis-4,7-methylidene)-methylene]-2,2′-di-
O-[3-(R)-7-dimethyloctyl]-1-O-[4-O-(â-D-galactopyranosyl)-â-D-glu-
copyranosyl]-1′-O-(â-D-galactofuranosyl)-sn-diglycerol (2). Follow-
ing the same strategy as for compound 1 and starting from alcohol 25,
compound 2 was obtained (first glycosylation: 50% yield; deprotec-
tion: 98% yield; second glycosylation: 58% yield; last deprotection:
86% yield), compound 2: Rf ) 0.7 (CHCl3/MeOH/H2O 7:3:0.5 v/v);
mp ) 196-199 °C, [R]20D -9.8° (c 0.86, MeOH); 1H NMR (400 MHz,
CDCl3) δ 0.59 (m, 1H), 0.80 (m, 18H), 0.95-1.68 (m, 51H), 3.14-
3.91 (m, 36H), 4.24 (2d, 2H, J ) 7.4 Hz), 4.80 (m, 1H); 13C NMR
(400 MHz, CDCl3) δ 20.19, 20.23, 23.1, 23.2, 25.9-40.5, 41.2, 41.4,
41.9, 61.9, 62.4, 64.5, 68.4, 69.6, 69.7, 70.2, 70.3, 70.0, 71.8, 72.4,
72.5, 72.6, 72.8, 74.7, 74.8, 76.3, 76.5, 77.1, 78.9, 79.2, 79.3, 80.5,
83.2, 84.6, 104.6, 105.1, 109.7; FABMS (m-nitrobenzyl alcohol matrix)
calcd for [M + Na]+, 1235.8220; found, 1235.8220.
>99%) as a colorless oil; Rf ) 0.4 (EP/EtOAc 6:4 v/v); [R]20 -3.2°
D
1
(c 1, CHCl3); H NMR (400 MHz, CDCl3) δ 0.52-0.61 (m, 1H, J )
9.9 Hz), 0.79-0.81 (m, 18H), 1.08-1.67 (m, 50H), 1.82-1.85 (m,
1H), 1.91-2.10 (6s, 21H), 3.31-3.63 (m, 18H), 3.75 (t, 1H, J ) 9.4
Hz), 3.82-3.86 (m, 2H), 4.00-4.10 (m, 3H), 4.40-4.45 (m, 2H), 4.49
(d, 1H, J ) 7.7 Hz), 4.82-4.86 (t, 1H, J ) 8.2 Hz), 4.89-4.92 (dd,
1H, J ) 3.3, 10.4 Hz), 5.01-5.06 (dd, 1H, J ) 8.1, 10.3 Hz), 5.13 (t,
1H, J ) 9.4 Hz), 5.28 (d, 1H, J ) 2.7 Hz); 13C NMR (400 MHz, CDCl3)
δ 19.6, 20.4, 20.8, 22.5, 22.6, 24.6-39.2, 40.7, 60.8, 62.0, 62.6, 66.6,
Acknowledgment. We thank Mrs. R. Kaiser for excellent
technical assistance in freeze-fracturing, Mr. F. Steiniger for
9
J. AM. CHEM. SOC. VOL. 126, NO. 32, 2004 10011